Elevance Health, Inc. ELV

396.09 (2.16) (0.54%) as of 25 Sep
Market cap
$86.4B
P/E
17.6×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
11.17% 12.10% 13.25% 12.58%

+8 more TTM periods

ROA
4.00% 4.27% 4.75% 4.62%
ROIC
11.83% 12.52% 12.74% 13.32%
Return on Tangible Assets
18.00% 19.87% 21.25% 20.08%
Average Days of Receivables
42.45 41.51 39.49 41.87
Free Cash Flow per Share
28.98 29.34 14.17 16.87
Free Cash Flow
6,289.00 6,450.00 3,174.00 3,767.00
Capital Expenditures
(1,175.00) (1,155.00) (1,116.00) (1,145.00)
Piotroski F-Score
5.00 6.00 5.00 4.00
Other line items
Cash ROIC
6.57% 6.78% 3.83% 4.38%
Accounts Receivable Turnover
8.65 8.91 9.81 9.56
Accounts Payable Turnover
6.89 7.01 7.20 7.38
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
53.66 52.83 52.59 51.29
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
(0.16) (0.16) (0.16) (0.22)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Share Based Compensation of Revenue
0.12% 0.12% 0.14% 0.11%
Interest Coverage
0.00 0.00 0.00 0.00
Operating CF/Net income
1.50 1.45 0.76 0.89
Depreciation/Fixed assets
0.33 0.33 0.33 0.33
Capex/Depreciation
(0.78) (0.76) (0.72) (0.74)
Revenue per Share
926.79 911.81 888.95 872.46
Operating CF per Share
34.40 34.60 19.15 22.00
Capex per Share
(5.41) (5.25) (4.98) (5.13)
Capex to Sales
0.01 0.01 0.01 0.01
Net Profit Margin
2.47% 2.62% 2.84% 2.84%

Fold the line items

Columns are period end dates